Journal
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 31, Issue 12, Pages 1290-1293Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/657332
Keywords
-
Funding
- Centers for Disease Control and Prevention (CDC) [UR8/CCU115079]
- National Institutes of Health [K23AI64161]
Ask authors/readers for more resources
Postdischarge risks of vancomycin-resistant Enterococcus (VRE) infection among carriers are unknown. We conducted a retrospective cohort study of 199 patients newly detected as VRE carriers. Fifteen patients (8%) developed 27 VRE infections in the 18 months after detection. Among 10 postdischarge infections, 2 involved bacteremia and 3 resulted in readmission.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
